Aug 5, 2026 04:01PM
Aug 4, 2026 04:01PM
Jul 28, 2026 07:00AM
Jul 14, 2026 08:00AM
Jul 14, 2026 08:00AM
Jul 1, 2026 04:01PM
Jun 11, 2026 07:03AM Syndax presents Revuforj clinical data across acute leukemia subtypes
Jun 11, 2026 07:03AM
Jun 11, 2026 07:02AM
Jun 11, 2026 07:00AM
Jun 4, 2026 04:01PM
Jun 4, 2026 07:00AM
Jun 4, 2026 07:00AM
Jun 2, 2026 04:01PM SYNDAX highlights revumenib post-transplant data at ASCO 2026
Jun 2, 2026 04:01PM
Jun 1, 2026 07:00AM
Jun 1, 2026 07:00AM
May 21, 2026 05:01PM
May 21, 2026 05:01PM
May 20, 2026 07:00AM
May 12, 2026 10:31AM Syndax Highlights 12 Revuforj® (revumenib) Abstracts Accepted for EHA 2026, Advancing Leadership in Menin Inhibition
May 6, 2026 04:01PM
Apr 30, 2026 04:01PM
Apr 24, 2026 07:00AM
Apr 3, 2026 04:01PM
Mar 4, 2026 04:01PM
Feb 26, 2026 04:01PM
Feb 23, 2026 07:00AM Syndax Announces Participation in March Investor Conferences
Feb 19, 2026 07:00AM
Feb 5, 2026 07:00AM
Feb 4, 2026 04:01PM
Jan 12, 2026 07:08AM
Jan 12, 2026 07:00AM
Jan 7, 2026 07:00AM
Jan 5, 2026 07:00AM Syndax Announces Presentation at the 44th Annual J.P. Morgan Healthcare Conference
Dec 12, 2025 07:00AM
Dec 9, 2025 04:34AM
Dec 8, 2025 06:50AM
Dec 8, 2025 06:50AM
Dec 3, 2025 04:01PM
Dec 1, 2025 07:00AM
Nov 5, 2025 04:01PM Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Nov 3, 2025 04:01PM
Nov 3, 2025 09:09AM
Nov 3, 2025 09:08AM
Nov 3, 2025 09:08AM
Oct 30, 2025 07:00AM
Oct 27, 2025 07:48AM
Oct 27, 2025 07:00AM Syndax to Announce Third Quarter 2025 Financial Results and Host Conference Call and Webcast on November 3, 2025
Oct 24, 2025 01:59PM

328,164 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All